Evidence map›Paper›PMID 29793058›Full record

ArticleInternational journal for parasitology. Drugs and drug resistance2018

The transcription factor SKN-1 and detoxification gene ugt-22 alter albendazole efficacy in Caenorhabditis elegans.

Pauline Fontaine, Keith Choe

Open access · goldAbstract read
In one paragraph

Article in International journal for parasitology. Drugs and drug resistance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Role of UDP-Glycosyltransferase (Chemical research in toxicology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in plant science · 2022
    Article
  8. Recent developments inDrug metabolism reviews · 2021
    Article
  9. Marine drugs · 2021
    Article
  10. Xenobiotic metabolism and transport inJournal of toxicology and environmental health. Part B, Critical reviews · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Pauline FontaineDepartment of Biology, University of Florida, Gainesville, FL 32611, USA.
Keith ChoeDepartment of Biology, University of Florida, Gainesville, FL 32611, USA. Electronic address: kchoe@ufl.edu.
University of Florida · US

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
NIH HHS P40 OD010440
6 · The paper itself

Abstract

Parasitic nematodes infect over 1/4 th of the human population and are a major burden on livestock and crop production. Benzimidazole class anthelmintics are widely used to treat infections, but resistance is a widespread problem. Mutation of genes encoding the benzimidazole target β-tubulin is a well-established mechanism of resistance, but recent evidence suggests that metabolism of the drugs may also occur. Our objective was to investigate contributions of the detoxification-response transcription factor SKN-1 to anthelmintic drug resistance using C. elegans. We find that skn-1 mutations alter EC

Indexed as

AlbendazoleAnimalsAnthelminticsCaenorhabditis elegansCaenorhabditis elegans ProteinsDNA-Binding ProteinsDrug ResistanceInactivation, MetabolicMutationTranscription FactorsTubulinAlbendazoleAnthelminticsCaenorhabditis elegans ProteinsDNA-Binding Proteinsskn-1 protein, C elegansTranscription FactorsTubulinAlbendazoleAnthelminticDetoxificationDrug resistanceParasite

Identifiers

PMID29793058
PMCPMC6039320
OpenAlexW2800616779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.